Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he has had discussions with his counterparts in (a) Scotland, (b) Wales and (c) Northern Ireland on equitable access to abiraterone acetate for high-risk, non-metastatic prostate cancer patients.

Decisions on the availability of medicines in Scotland, Wales, and Northern Ireland are a matter for the devolved administrations.